• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of October 17, 2012

  • Print
  • Share
  • E-mail
-

Event Detail

Event ID 54950
Product Type Biologics
Status Terminated
Recalling Firm CSL Plasma, Inc.
City Boca Raton
State FL
Country US
Voluntary/Mandated Voluntary: Firm Initiated
Recall Initiation Date 2010-01-29
Initial Firm Notification of
Consignee or Public
Other
Distribution Pattern IL, Switzerland, Germany

Product Detail

Product Description Code Info Classification Reason for Recall Product Quantity Recall Number
Source Plasma 4140613225; 4140612523; 4140581482; 4140580782; 4140578837; 4140577908; 4140575951; 4140575036; 4140572923; 4140572023; 4140570304; 4140569645; 4140567576; 4140566265; 4140564698; 4140563245; 4140561679; 4140560376; 4140557425; 4140554999; 4140553972; 4140526449; 4140497533; 4140496378; 4140493098; 4140490859; 4140489881; 4140485193; 4140483573; 4140481484; 4140479914; 4140477740; 4140476696; 4140473287; 4140471125; 4140470089; 4140467939; 4140466345; 4140464890; 4140450547; 4140446540; 4140445479; 4140443871; 4140441426; 4140440699; 4140437662; 4140428864; 4140426883; 4140425978; 4140421489; 4140420581; 4140418186; 4140417609; 4140415423; 4140414696; 4140412624; 4140411954; 4140407551; 4140406574; 4140404641; 4140403233; 4140401772; 4140396726; 4140395141; 4140393701; 4140392195; 4140390838; 4140388946; 4140384411; 4140382992; 4140381378; 4140379502; 4140378027; 4140372101; 4140371139; 4140369324; 4140367440; 4140366542; 4140364365; 4140363574; 4140280861; 4140278756; 4140277773; 4140275407; 4140274524; 4140272672; 4140271809; 4140269889; 4140268100; 4140267275; 4140263303; 4140261905; 4140260453; 4140258970; 4140257679; 4140255588; 4140254264; 4140250919; 4140249596; 4140248130; 4140246765; 4140245406; 4140244065; 4140225325; 4140223493; 4140221844; 4140221072; 4140217378; 4140216493; 4140214814; 4140214030; 4140212214; 4140211478; 4140209774; 4140209001; 4140205337; 4140204469; 4140202914; 4140202111; 4140196246; 4140194848; 4140193691; 4140192470; 4140190797; 4140190016; 4140164810; 4140163986; 4140160621; 4140159164; 4140156438; 4140154970; 4140152719; 4140151909; 4140150500; 4140149432; 4140148224; 4140146839; 4140145321; 4140143399; 4140142605; 4140140678; 4140139919; 4140136502; 4140135390; 4140134026; 4140132464; 4140130969; 4140130258; 4140119613; 4140117241; 4140116168; 4140115037; 4140113992; 4140112986; 4140111846; 4140110755; 4140107327; 4140106209; 4140105241; 4140104023; 4140102679; 4140101997; 4140099247; 4140097860; 4140097129; 4140095718; 4140095099; 4140093901; 4140093053; 4140092135; 4140090007; 4140089126; 4140087789; 4140087212; 4140086061; 4140085472; 4140081408; 4140080632; 4140079501; 4140078702; 4140077848; 4140076758; 4140075734; 4140075023; 4140074324; 4140073742; 4140072670; 4140072092; 4140054330; 4140053881; 4140052807; 4140052261; 4140051221; 4140050170; 4140049582; 4140048233; 4140047761; 4140046724; 4140046278; 4140045354; 4140044856; 4140043873; 4140043449; 4140042171; 4140041556; 4140040598; 4140040076; 4140039174; 4140038586; 4140037748; 4140037331; 4140036303; 4140035806; 4140034671; 4140034195; 4140033318; 4140032865; 4140032049; 4140031663; 4140024779; 4140024261; 4140023308; 4140022789; 4140021629; 4140021160; 4140020324; 4140008740; Class II Blood products, collected from donors who were previously deferred for high risk behavior, were distributed. 227 B-1993-12
-
-